DERM — Journey Medical Balance Sheet
0.000.00%
- $172.59m
- $177.79m
- $56.13m
- 47
- 22
- 95
- 55
Annual balance sheet for Journey Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 8.25 | 49.1 | 32 | 27.4 | 20.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 23.9 | 23.1 | 28.2 | 15.2 | 10.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 35.2 | 84.5 | 77.7 | 56.5 | 48.2 |
Net Property, Plant And Equipment | 0.175 | 0.089 | 0.189 | 0.101 | 0.199 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 51.9 | 97.3 | 105 | 76.8 | 80.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 28.1 | 51.6 | 66.8 | 41.9 | 35.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 41.6 | 55.2 | 88.2 | 56.5 | 60.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 10.3 | 42 | 17 | 20.4 | 20.1 |
Total Liabilities & Shareholders' Equity | 51.9 | 97.3 | 105 | 76.8 | 80.2 |
Total Common Shares Outstanding |